Overview

Vapocoolant Spray for Reducing the Pain of Spinal Needle Insertion

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
0
Participant gender:
All
Summary
This was a single-blind, randomized controlled trial. Sixty-six patients who underwent caudal epidural injection were randomized into the vapocoolant spray group or local infiltration group. Before the insertion of a 20-gauge spinal needle, the subcutaneous tissue was infiltrated with 3 ml of 2% lidocaine in the local infiltration group and vapocoolant spray was applied just before the spinal needle insertion in the spray group. 100-mm visual analog scale to evaluate the pain intensity of spinal needle insertion and a five-point Likert scale for patient satisfaction and preference for repeated use were compared between the two groups.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
The Catholic University of Korea
Collaborator:
Soonchunhyang University Hospital
Treatments:
Lidocaine
Criteria
Inclusion Criteria:

- patients with low back pain and radiating pain in the lower limb who underwent a
scheduled caudal epidural injection

Exclusion Criteria:

- those who had systemic inflammatory disease, those who take anticoagulant
administration, those who had uncontrolled diabetes, those who were unable to
understand a visual analog scale (VAS) or a Likert scale, those with a history of cold
intolerance or cold allergy, those with a history of allergic reaction to lidocaine,
those who took pain medications or had used topical anesthetics within the previous 24
hrs, those who had a skin lesion on the sacral hiatus, and those who had the
experience of caudal epidural injection